Context Therapeutics Inc
Biotechnology
Healthcare
CNTX
15.97 M shares
NASDAQ US
traded
11 Oct 2023
listed
yes
open
1.28
52 week high
7.45
high
1.37
52 week low
1.32
low
1.28
growth
0.75 %
previous Close
1.33
P/E ratio
market cap
15.97 M
div yield
0
usd
Sep 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top